Takahiro Nagashima

Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan

Yongzhen Hu, Keita Kirito, Kozue Yoshida et al. · Molecular Cancer Therapeutics · 2009 · 52 citations

Medicine, Oncology, Pharmacology +17

Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

Yoji Ishida, Kazunori Murai, Kohei Yamaguchi et al. · European Journal of Clinical Pharmacology · 2015 · 50 citations

Medicine, Pharmacokinetics, Pharmacology +6

Phosphorylation of Fanconi Anemia Protein, FANCA, Is Regulated by Akt Kinase

Tetsuya Otsuki, Takahiro Nagashima, Norio Komatsu et al. · Biochemical and Biophysical Research Communications · 2002 · 21 citations

Life Sciences, Biochemistry, Molecular Biology +14

High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia

Hajime Senjo, Masahiro Onozawa, Daisuke Hidaka et al. · Scientific Reports · 2022 · 20 citations · Full text

Medicine, Hematology, Oncology +13

Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study

Daisuke Hidaka, Masahiro Onozawa, Junichi Hashiguchi et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 17 citations · Full text

Life Sciences, Genetics, Oncology +15